BNET Industries
Market Cap:$96.1M
Last Fiscal Year Sales:$51.6M
- Public
- US
Dow Jones Description
Rockwell started in January 1995, with four employees, when it began manufacturing and distributing dialysis kits and other ancillary dialysis products. In January of 1996, the Company moved into a new 35,000 square foot manufacturing plant and began production and distribution of acid concentrate and bicarbonate along with ancillary dialysis products. The Company successfully completed an initial public offering (IPO) in January of 1998 and began trading on the NASDAQ Exchange under the symbol RMTI. In 1998, after several months of development, the Company successfully launched two new and innovative products. Both products, Dri-Sate Dry Acid Concentrate and SteriLyte Liquid Bicarbonate, were advancements over current industry technology and made a positive and immediate impact throughout the dialysis provider market. By the beginning of 2001 the Company had outgrown its original plant, and in July of 2001, to accommodate its expansion, Rockwell took occupancy of a new 51,000 square foot manufacturing plant. The new plant, which was designed with more efficient operating processes, would serve as the prototype for the Company's manufacturing expansion going forward. In order to accommodate its growing dialysis concentrate business, Rockwell opened its second 51,000 square foot manufacturing facility in October of 2001, in Grapevine, Texas. Designed to streamline manufacturing and distribution of all Rockwell products, the new plant was a significant and strategic step in...
Founder, Chairman, Chief Executive Officer and PresidentRobert L. Chioini
Number of Employees 250
Peer Companies
NAICS Code Electromedical and Electrotherapeutic Apparatus Manufacturing: 334510
Recent Events
-
Rockwell Medical Technologies RMTI Reports Results for First Quarter 2009
-
Rockwell Medical Technologies, Inc. Reports Fourth Quarter 2008 Results; Sales Increase 20% Year-Over-Year to $51.6...
-
Rockwell Medical Technologies, Inc. Appoints Richard Yocum, M.D. as VP of Drug Development and Medical...
News & Analysis
Filter by
rockwell medical technologies inc. - All News and Analysis
Update on Rockwell Medical's Phase 2b Trial
Mike Havrilla submits: Rockwell Medical (NASDAQ:RMTI) announced yesterday that patient enrollment is completed for the Company's ongoing Phase 2b dose-ranging study for its iron replacement therapy soluble ferric pyrophosphate SFP. Below is the entry from RMTI in the BioMedReports.com Clinical Trial Calendar database: RMTI is developing a water soluble iron...
Rockwell Medical Technologies: Improving Margins, Banking on SFP
Mike Havrilla submits: In mid-March, Rockwell Medical Technologies RMTI reported 4Q and FY08 results which included revenue of $13.5M (up 13.3% from year-ago quarter) and $51.6M (up 20% compared to 2007). The net losses were ($3M) and ($7.9M) for 4Q and FY08, respectively. Despite solid sales growth, RMTI has posted...
Rockwell Medical Technologies, Inc. Q3 2008 Earnings Call Transcript
Question-and-Answer Session Operator Operator instructions We’ll have our first question from Todd Lewis [ph], South Street Capital [ph]. Todd Lewis – South Street Capital Hey, guys. Good quarter. Thanks for taking my call. Just a quick question for you. You mentioned the potential for SFP extensions and opportunities in...
Rockwell Medical Technologies, Inc. Receives Nasdaq Notification of Continued Nasdaq Listing
Business Editors WIXOM, Mich.--BUSINESS WIRE--July 12, 2001 Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative hemodialysis concentrate manufacturer in the healthcare industry, announced today that it has been notified by Nasdaq that the Company has demonstrated compliance with Nasdaq's listing requirements and that the Company's common stock will...
Rockwell Medical Technologies, Inc. Receives Nasdaq Staff Determination
Business Editors & Health/Medical Writers WIXOM, Mich.--BUSINESS WIRE--May 15, 2001 Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative hemodialysis concentrate manufacturer in the healthcare industry, said today that it received a Nasdaq Staff Determination on May 8, 2001, that the Company does not comply with the $1.00 minimum...
Additional Resources
ROCKWELL MEDICAL ANNOUNCES UPDATED DSMB RESULTS.(Financial report)
Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), Wixom, Mich., a specialty pharma company focused on drug and device development in the renal market, has reported that the independent Data Safety Monitoring Board DSMB providing oversight for the SFP Phase II-b iron maintenance therapy dose-range study reviewed the cumulative...
Rockwell Medical Technologies, Inc. to Present at JMP Securities Healthcare Focus Conference
WIXOM, Mich. -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative manufacturer and developer of renal drug therapies and essential dialysate products, focused on the end-stage-renal-disease ESRD market, today announced that Robert L. Chioini, President and CEO of Rockwell, will present an overview of the Company at the JMP Securities...
Fundamental Review for Rockwell Medical Technologies, Inc.
M2 PRESSWIRE-11 May 2007-Biotech News: Fundamental Review for Rockwell Medical Technologies, Inc.C1994-2007 M2 COMMUNICATIONS LTD RDATE:11052007 Rockwell Medical Technologies keeps on trucking with its hemodialysis products. The company makes hemodialysis concentrates in liquid and dry powder form, dialysis kits, and other...
Rockwell Medical Technologies Inc. Under Current Review.
M2 PRESSWIRE-25 January 2007-www.streetinvesting.com: Rockwell Medical Technologies Inc. Under Current ReviewC1994-2007 M2 COMMUNICATIONS LTD RDATE:25012006 Please visit www.Streetinvesting.com for the full report. The phenomenal success that North American Markets were subject to on Tuesday continued Wednesday. While the...
Rockwell battles competitor over name of dialysis product; Lawsuits filed over product names Dryalysate, Dri-sate.(News)(Rockwell Medical Technologies Inc v Advanced Renal Technologies)(trademark infringement case)(Case overview)
Byline: Andrew Dietderich Wixom-based Rockwell Medical Technologies Inc. is locked in a legal battle over a product that has served as a building block to its growth from startup to a $28 million company. Bellevue, Wash.-based Advanced Renal Technologies filed suit ...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Thomas E. Klema | Vice President, Cfo |
| Richard Yocum | Vice President, Drug Dev & Medical Affairs |
| Larry Wheatley | Projects Operations Manager |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Robert L. Chioini | Founder, Chairman, Chief Executive Officer and President |
| Kenneth L. Holt | Board of Directors |
| Patrick J. Bagley | Board of Directors |
| Ronald D. Boyd | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Rockwell Medical Technologies, Inc. | Founder, Chairman, Chief Executive Officer and President | Current |
| Rockwell Medical Technologies, Inc. | Director | Former |
| Michigan State University | Former |
| Organization | Position | Status |
|---|---|---|
| Rockwell Medical Technologies, Inc. | Vice President, Cfo | Current |
| Whistler.Com | Vice President of Finance and Administration | Former |
| Mol-Son | Former | |
| Rockwell Medical Technologies, Inc. | Board of Directors | Former |
| Michigan State University | Master of Business Administration Degree | Former |
| Michigan State University | Business Administration Degree In 1977 | Former |
| Organization | Position | Status |
|---|---|---|
| Rockwell Medical Technologies, Inc. | Vice President, Drug Dev & Medical Affairs | Current |
| Organization | Position | Status |
|---|---|---|
| DFW Ifma | First Vice President | Current |
| Rockwell Medical Technologies, Inc. | Projects Operations Manager | Current |
| DFW Ifma | Board of Directors | Current |
| Ifma | Board of Directors | Current |
| Northwood University | Bba In Management, Marketing | Former |
| Organization | Position | Status |
|---|---|---|
| Rockwell Medical Technologies, Inc. | Board of Directors | Current |
| Gambro Healthcare, Inc. | Vice President | Former |
| Organization | Position | Status |
|---|---|---|
| Rockwell Medical Technologies, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Rockwell Medical Technologies, Inc. | Board of Directors | Current |
| Future Tech | Regional Sales Manager | Former |
Industry Transcripts by Seeking Alpha
-
Sun Healthcare Group, Inc., Q1 2009 Earnings Call Transcript
on May 27, 2009about SUNH
-
Aflac Incorporated 2009 Financial Analyst Briefing Transcript
on May 20, 2009about AFL
-
Medtronic, Inc. F4Q09 (Qtr End 04/24/09) Earnings Call Transcript
on May 19, 2009about MDT
-
Thoratec Corporation Q1 2009 Earnings Call Transcript
on May 11, 2009about THOR
-
ResMed F3Q09 (Qtr End 3/31/09) Earnings Call Transcript
on May 07, 2009about RMD